This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Ingredion-Tate & Lyle deal may hinge on specialty ingredient overlaps

By Jon Menon ( June 12, 2026, 14:25 GMT | Comment) -- Ingredion's planned £2.7 billion buyout of British rival Tate & Lyle may face scrutiny over potential overlaps in specialty food ingredients used to improve sweetness, texture and mouthfeel in packaged food and drink. The companies have started laying the groundwork for arguing that they have complementary product lines and that the deal builds a more resilient supply chain for their customers.Ingredion's planned £2.7 billion ($3.6 billion) buyout of British rival Tate & Lyle may face scrutiny over potential overlaps in specialty food ingredients used to improve sweetness, texture and mouthfeel in packaged food and drink....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login